Journal of Virology · 2020 · 29 citations · 67 references
Life SciencesBiologyMolecular BiologyMolecular VirologyStructural BiologyVirologyRna-binding ProteinsViral GeneticsViral ReplicationViral Rna BiologyViral StructureVirus-host InteractionsProtein-protein Interaction Interface PredictionProtein-protein Interface AnalysisRna Virus BiologyViral Matrix ProteinsViral Nucleocapsid StructureViral Replication ComplexesViral Rna Replication ComplexesViral Rna Synthesis
Alternative treatments to combat rotavirus infection are a requirement for susceptible communities where vaccines cannot be applied. This demand is urgent for newborn infants, immunocompromised patients, adults traveling to high-risk regions, and even for the livestock industry. Aside from structural and physiological divergences among RV species studied before now, all replicate within cytosolic inclusions termed viroplasms. These inclusions are composed of viral and cellular proteins and viral RNA. Viroplasm-like structures (VLS), composed of RV protein NSP5 with either NSP2 or VP2, are models for investigating viroplasms. In this study, we identified a conserved amino acid in the VP2 protein, L124, necessary for its interaction with NSP5 and the formation of both VLSs and viroplasms. As RV vaccines cover a narrow range of viral strains, the identification of VP2 L124 residue lays the foundations for the design of drugs that specifically block NSP5-VP2 interaction as a broad-spectrum RV antiviral.
67
Clustal W and Clustal X version 2.0
Mark Larkin, Gordon Blackshields, Nigel P. Brown et al. · Bioinformatics · 2007 · 29.1K citations · Full text
Jalview Version 2—a multiple sequence alignment editor and analysis workbench
Andrew Waterhouse, James B Procter, David Martin et al. · Bioinformatics · 2009 · 10.9K citations · Full text
Thomas R. Fuerst, Edward G. Niles, F. William Studier et al. · Proceedings of the National Academy of Sciences · 1986 · 2.1K citations · Full text